CRISPR'd babies: human germline genome editing in the 'He Jiankui affair'
- PMID: 31666967
- PMCID: PMC6813942
- DOI: 10.1093/jlb/lsz010
CRISPR'd babies: human germline genome editing in the 'He Jiankui affair'
Abstract
The world was shocked in Nov. 25, 2018 by the revelation that He Jiankui had used clustered regularly interspaced short palindromic repeats ('CRISPR') to edit embryos-two of which had, sometime in October, become living babies. This article is an effort to provide some deep context for the He Jiankui affair and to begin analyzing it. It focuses on He's experiment, without delving into the broader ethical issues around 'human germline genome editing' in the abstract. It begins by carefully defining 'human germline genome editing'. It then describes the little we know about the experiment before providing background on CRISPR, the pre-He ethical and legal status of human germline genome editing, and on He himself. The fourth, and longest, section provides a detailed narrative of the revelation of the He experiment and its fallout. The fifth section critiques the experiment, which I believe merits unequivocal condemnation on several grounds. The last section suggests some important immediate reactions, by 'Science' and by China.
Keywords: CRISPR; Germline genome editing; He Jiankui; assisted reproduction; ethics; eugenics.
© The Author(s) 2019. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School.
Similar articles
-
He Jiankui´s gene-editing experiment and the non-identity problem.Bioethics. 2021 Jul;35(6):563-573. doi: 10.1111/bioe.12878. Epub 2021 May 5. Bioethics. 2021. PMID: 33951203 Free PMC article.
-
Realigning gene editing with clinical research ethics: What the "CRISPR Twins" debacle means for Chinese and international research ethics governance.Account Res. 2019 May;26(4):257-264. doi: 10.1080/08989621.2019.1617138. Epub 2019 May 17. Account Res. 2019. PMID: 31068009
-
Genetically Modified Babies and a First Application of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR-Cas9).Obstet Gynecol. 2019 Jul;134(1):157-162. doi: 10.1097/AOG.0000000000003327. Obstet Gynecol. 2019. PMID: 31188312
-
Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.Hum Reprod Update. 2016 Jun;22(4):411-9. doi: 10.1093/humupd/dmw005. Epub 2016 Feb 29. Hum Reprod Update. 2016. PMID: 26932460 Review.
-
Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate.Per Med. 2016 Nov;13(6):575-586. doi: 10.2217/pme-2016-0047. Epub 2016 Oct 28. Per Med. 2016. PMID: 28757883 Free PMC article. Review.
Cited by
-
Application of CRISPR-Cas9 genome editing technology in various fields: A review.Narra J. 2023 Aug;3(2):e184. doi: 10.52225/narra.v3i2.184. Epub 2023 Aug 27. Narra J. 2023. PMID: 38450259 Free PMC article. Review.
-
Knowledge of and attitudes towards medical research ethics among first year doctoral students in Slovenia at the Faculty of Medicine, University of Ljubljana.BMC Med Educ. 2023 Nov 3;23(1):828. doi: 10.1186/s12909-023-04809-w. BMC Med Educ. 2023. PMID: 37924025 Free PMC article.
-
CRISPR/Cas9 technology: applications in oocytes and early embryos.J Transl Med. 2023 Oct 24;21(1):746. doi: 10.1186/s12967-023-04610-9. J Transl Med. 2023. PMID: 37875936 Free PMC article. Review.
-
Researching the future: scenarios to explore the future of human genome editing.BMC Med Ethics. 2023 Sep 21;24(1):72. doi: 10.1186/s12910-023-00951-8. BMC Med Ethics. 2023. PMID: 37735670 Free PMC article.
-
Analysis of ethics dumping and proposed solutions in the field of biomedical research in China.Front Pharmacol. 2023 Aug 28;14:1214590. doi: 10.3389/fphar.2023.1214590. eCollection 2023. Front Pharmacol. 2023. PMID: 37701030 Free PMC article.
LinkOut - more resources
Full Text Sources
